Sotuvning operatsion marjasi: Compugen Limited (CGEN)

Compugen Ltd (CGEN) kompaniyasining korporativ logotipi

Compugen Ltd. intellektual mulk huquqlarini saqlab qolgan holda, dastlabki klinik sinovlarni tashqi pudratchilarga topshiradi va oqsil nishanlarini aniqlashni tezlashtirish uchun AI platformalarini joriy etadi. GURU.Markets platformasidagi operatsion daromad marjasi biznes samaradorligini aks ettiradi va ushbu ko'rsatkich hozirda 41.30 darajasida turibdi. Rivojlanishning asosi neyron tarmoqlari orqali yangi dori nishanlarini aniqlashga asoslangan holda sog'liqni saqlash gigantlari bilan tuzilgan litsenziyalash shartnomalaridan iborat.

CGEN: Compugen Ltd Operatsion foyda normasi 04.07.2022 - 19.11.2026

Compugen Ltd - tahliliy kesimlar va asosiy koʻrsatkichlar (CGEN)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:CGEN, cgen.com
Compugen asosiy tovari

Aktivlar qiymati va biznes sifati o'rtasidagi muvozanatni topish xarajatlarni boshqarish samaradorligini tahlil qilishni talab qiladi. Ushbu ko'rsatkich soliqlar va qarz yuklamasi ta'sirini hisobga olmagan holda, umumiy daromadlarda operatsion foydaning ulushini belgilaydi. Compugen Ltd. (CGEN) uchun ushbu metrika immunoterapiya sohasidagi sog'liqni saqlash gigantlari bilan ittifoqlarni monetizatsiya qilish qobiliyatini ifodalaydi. Marjaning o'sishi ilmiy yutuqlarning kengaytiriluvchanligini tasdiqlaydi. Operatsion rentabellik tarixi modelning xarajatlarga nisbatan barqarorligini ko'rsatadi.

Compugen Ltd. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|IO Biotech Inc - Sotuvning operatsion marjasi|sutrobio.com (STRO) - Sotuvning operatsion rentabelligi|INKT - Operatsion rentabellik|werewolftx.com (HOWL) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja